Taysha Gene Therapies, Inc.TSHANASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
16.24%
↓ 97% below average
Average (5y)
565.44%
Historical baseline
Range
High:3131.31%
Low:-37.72%
Volatility
560.5%
High variability
| Period | Value |
|---|---|
| 2024 | 16.24% |
| 2023 | -37.72% |
| 2022 | -30.90% |
| 2021 | 313.71% |
| 2020 | 3131.31% |
| 2019 | 0.00% |